Back to search

Boston University

The mechanistic understanding of the prothrombotic role of GLP-1 agonist

Abstract

dc:description.abstract

Each year, 1.2 million people are newly diagnosed with diabetes every year which has become the eighth leading cause of death in the United States (American Diabetes Association [ADA], 2025). Type II diabetes (T2DM), is a metabolic disorder resulting in an imbalance of insulin availability, thereby leaving room for a range of comorbidities. Semaglutide, an incretin-based therapy, is revolutionizing the way T2DM and obesity arw treated within the United States. However, the thrombogenic side effects remain under-appreciated despite a previous meta-analysis indicating a 266% risk increase in deep vein thrombosis (Yin et al., 2021). This study is the first step toward examining semaglutide induced thrombogenicity. An inferior vena cava (IVC) ligation with diet-induced obesity mice model was used to mimic thrombosis in type II diabetic populations. Mice were given a cafeteria and high fat diet ad libitum for 6 weeks and received 40 uL/kg intraperitoneal injections of semaglutide daily for 14 days. Mouse weight was recorded weekly. IVCs with subsequent clots were harvested and underwent immunofluorescence staining for tissue factor, PAI-1, von Willebrand factor, and thrombomodulin. Our results communicated that male mice had, there was an upregulation of tissue factor, PAI-1, and vWF while on semaglutide. There was no significant difference noted in the systemic coagulation profile, however, locally, there was an increase in the prothrombotic mediators. This may explain the increased propensity for high thrombogenicity under semaglutide. This study explains a potential side effect of semaglutide which remains under-appreciated.

Degree

thesis:*
Name thesis:degree_name
Master of Science
Level thesis:degree_level
masters
Discipline thesis:degree_discipline
Medical Sciences
Grantor
Boston University
Year dc:date.issued
2025

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Przekop, Kylla
Advisor dc:contributor.advisor
  • Chitalia, Vipul

Subjects

dc:subject × 3

Rights

Language dc:language.iso
en_US

Identifiers

dc:identifier.*
Handle dc:identifier.uri
https://hdl.handle.net/2144/52355

Chain of custody

source
Harvested from
Boston University
Base URL
open.bu.edu/oai/request
Last updated
2026-11-19
Source record
OAI-PMH GetRecord
citation

Przekop, Kylla. The mechanistic understanding of the prothrombotic role of GLP-1 agonist. masters thesis, Boston University, 2025. https://hdl.handle.net/2144/52355